Exploring Sunresin New Materials Co.,Ltd Investor Profile: Who’s Buying and Why?

CN | Basic Materials | Chemicals | SHZ

Sunresin New Materials Co.,Ltd (300487.SZ) Bundle

Get Full Bundle:
$25 $15
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7

TOTAL:

Curious who's backing Sunresin New Materials Co., Ltd. (300487.SZ)? With CEO Xiaokang Kou owning a commanding ≈24% stake and institutional investors holding about 17%-led by China Life Insurance at 8.12% and Shanghai Guojin at 5.39%-the ownership mix (top three controlling over 47% while the public float sits at 50.92%) reveals a powerful blend of insider conviction and notable institutional faith as of August 2025; combine that with a stock price of CNY 61.52, market cap of CNY 31.20 billion, P/E of 37.29, Q3 2025 net profit of CNY 652 million (up 9.27% YoY) and a low beta of 0.41-and you have the data-driven reasons investors are reallocating capital into Sunresin's research-led growth story, compelling a deeper look into who's buying and why.

Sunresin New Materials Co.,Ltd (300487.SZ) - Who Invests in Sunresin New Materials Co.,Ltd and Why?

Sunresin's shareholder structure as of August 2025 shows concentrated insider ownership combined with a sizable public float and meaningful institutional participation, reflecting mixed motivations from control, strategic partnership to growth-investment bets.
Shareholder Type Approx. Stake (%)
Kou Xiaokang (CEO) Insider 24.00
China Life Insurance Co., Ltd. Institutional 8.12
Shanghai Guojin Investment Co., Ltd. Institutional 5.39
Other Institutional Investors (collective) Institutional ~3.49
Public / Individual Investors (float) Retail 50.92
  • Insider confidence: CEO Kou's ~24% stake signals strong alignment between management and minority shareholders and reduces risk of agency conflicts.
  • Institutional interest (~17% total): attracts more disciplined capital and suggests banks, insurers and asset managers view Sunresin as a strategic play in specialty resins and separation technologies.
  • Retail/public float (~50.92%): provides liquidity and enables market-driven price discovery; individual investors often respond to growth narratives and policy tailwinds.
Key investor motives and themes:
  • Market leadership in ion exchange resins and specialty polymer materials-investors targeting sector consolidation and tech differentiation.
  • Exposure to water treatment, chemical recycling, and high-value separations-sectors with steady industrial demand and regulatory support.
  • Alignment with management-large CEO holding reduces dilution risk and signals long-term commitment to value creation.
  • Stable institutional backing-life insurers and state-affiliated investment firms provide capital stability and potential for strategic partnerships.
Relevant investor details and context:
  • China Life's 8.12% stake - typical of long-duration institutional portfolios seeking stable industrial exposures with dividend/cashflow potential.
  • Shanghai Guojin's 5.39% - suggests regional strategic or state-linked investor interest in manufacturing/advanced materials capabilities.
  • Public float at 50.92% - enables active trading and participation by domestic retail platforms and quant/ETF strategies.
For deeper background on company ownership, history and business model see: Sunresin New Materials Co.,Ltd: History, Ownership, Mission, How It Works & Makes Money

Sunresin New Materials Co.,Ltd (300487.SZ) Institutional Ownership and Major Shareholders of Sunresin New Materials Co.,Ltd (300487.SZ)

Sunresin New Materials Co.,Ltd exhibits concentrated insider and institutional ownership, reflecting alignment between management and large investors and indicating significant influence from a few holders over corporate direction and strategy.
  • Largest individual shareholder: CEO Xiaokang Kou - ~24% ownership.
  • Major institutional investors include China Life Insurance Co., Ltd. (8.12%) and Shanghai Guojin Investment Co., Ltd. (5.39%).
  • Public float / free float is approximately 50.92%, with remaining shares held by other individual and institutional investors.
Rank Shareholder Stake (%) Notes
1 Xiaokang Kou (CEO) ~24.00 Largest single shareholder; significant insider control
2 China Life Insurance Co., Ltd. 8.12 Major institutional strategic investor
3 Shanghai Guojin Investment Co., Ltd. 5.39 Significant institutional holding
4 Other institutional holders (aggregate) ~10.57 Includes various funds and insurance companies
5 Public / Individual investors (free float) 50.92 Retail and smaller institutional investors
Top three shareholders (collective) Over 47% (combined influence)
  • High insider stake by the CEO combined with meaningful positions from insurers and state-linked investors suggests confidence in Sunresin's long-term strategy and financial health.
  • Institutional presence (insurance, state investment) supports stability but also concentrates voting power among a few large holders.
Sunresin New Materials Co.,Ltd: History, Ownership, Mission, How It Works & Makes Money

Sunresin New Materials Co.,Ltd (300487.SZ) Key Investors and Their Impact on Sunresin New Materials Co.,Ltd (300487.SZ)

Sunresin New Materials Co.,Ltd presents a shareholder base where insider and institutional stakes meaningfully shape governance, capital access and strategic direction. Major reported shareholdings and their implications:
  • CEO Xiaokang Kou - 24%: significant insider ownership aligning management incentives with minority shareholders and strengthening stewardship over long-term strategy.
  • China Life Insurance Co., Ltd. - 8.12%: a large state-linked institutional investor whose participation signals confidence to other institutions and can improve access to long-term capital.
  • Shanghai Guojin Investment Co., Ltd. - 5.39%: a strategic/sovereign investor stake that can offer policy-level support and industry connections.
Shareholder Stake (%) Significance/Impact
CEO Xiaokang Kou 24.00 Strong alignment of executive incentives with shareholder value; central influence on board and strategy.
China Life Insurance Co., Ltd. 8.12 Institutional endorsement that may attract additional institutional flows and lower perceived risk.
Shanghai Guojin Investment Co., Ltd. 5.39 Strategic investor potentially providing policy insight and market positioning advantages.
Top three shareholders (reported) 47.00 Concentrated ownership enabling coordinated strategic decisions and potential control over key corporate actions.
Key governance and market implications:
  • High insider ownership (CEO 24%) tends to reduce agency conflict and increase management accountability to shareholders.
  • Substantial institutional holdings (e.g., China Life) often improve liquidity, reduce cost of capital, and attract follow-on institutional investors.
  • Concentrated top-shareholder control (reported combined 47%) can accelerate decision-making on M&A, capex and strategy but may raise minority-shareholder governance considerations.
For broader context on Sunresin's background, ownership evolution and business model see: Sunresin New Materials Co.,Ltd: History, Ownership, Mission, How It Works & Makes Money

Sunresin New Materials Co.,Ltd (300487.SZ) - Market Impact and Investor Sentiment

As of December 12, 2025, Sunresin New Materials Co.,Ltd (300487.SZ) exhibits signs of solid investor confidence driven by steady earnings growth, strategic positioning in research-intensive markets, and low market volatility. Key headline metrics and contextual factors below highlight who is buying the stock and why.

Metric Value Notes
Share Price (12-Dec-2025) CNY 61.52 Price reflects a 12.69% increase (period-to-date)
Market Capitalization CNY 31.20 billion Mid-cap positioning in Chinese materials sector
P/E Ratio 37.29 Signals investor optimism and growth expectations
Q3 2025 Net Profit CNY 652 million Up 9.27% YoY
Beta 0.41 Lower volatility vs. broader market - attractive to risk-averse investors
Strategic Focus Life sciences, sustainable technologies, research-intensive applications Positioned in higher-margin, fast-growing end markets
  • Primary investor cohorts: domestic institutional investors (mutual funds, asset managers), specialized thematic funds (life-sciences and sustainability), and conservative retail investors seeking low-volatility exposure.
  • Growth-oriented investors attracted by above-market revenue and profit growth in Q3 2025 (net profit +9.27% YoY) and premium P/E reflecting expected earnings expansion.
  • Risk-averse buyers favor Sunresin for its low beta (0.41), which provides defensive positioning within cyclical materials sector allocations.

Drivers of buying interest include:

  • Structural demand: Rising need for high-performance resins and separation media in life sciences and environmental applications.
  • R&D-led product pipeline: Focus on research-intensive applications that command pricing power and differentiation.
  • Financial momentum: Recent share-price appreciation (12.69%) alongside improved quarterly profitability reinforces positive sentiment.

Relative valuation and sentiment snapshot:

Indicator Interpretation
P/E = 37.29 Higher-than-market multiple indicating growth premium and investor optimism
Beta = 0.41 Defensive profile; appeals to conservative portfolios and liability-matching strategies
Market Cap = CNY 31.20B Large enough for institutional interest, small enough for growth upside

For a deeper dive into the company's financial condition and implications for investors, see: Breaking Down Sunresin New Materials Co.,Ltd Financial Health: Key Insights for Investors

DCF model

Sunresin New Materials Co.,Ltd (300487.SZ) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.